Advaita just secured the final installment of a $125,000 in seed capital from the Michigan Emerging Technologies Fund, which is the latest in large amount of funding the bio-tech firm has secured.
Advaita is leveraging technology developed at Wayne State University. The 7-year-old start-up is developing a bioinformatics software solution called Pathway-Guide that provides gene pathway analysis technology. Pathway-Guide helps researchers trying to understand the data generated by high-throughput experiments, including next-generation sequencing. The technology looks to eliminate many false positives in diagnosis, as well as correctly identify biologically meaningful pathways in a given disease.
"It's a tremendous tool that will help people understand the mechanics of disease," says Sorin Draghici, president, CEO & founder of
Advaita. He is also a computer science professor at Wayne State University who discovered the technology.
Advaita secured a $2.2 million Phase II Small Business Technology Transfer grant last year. That seed capital, along with the Michigan Emerging Technologies Fund cash, has allowed the company and its six people to begin commercializing the technology.
"We're selling this," Draghici says. "The product is ready. We have already sold this to a couple of research universities."
Source: Sorin Draghici, president, CEO & founder of Advaita
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.